title: [Adjuvant therapy of colon cancer. State of the art and future perspectives].
authors.forename: S
authors.initials: S
authors.lastname: Barni
authors.forename: S
authors.initials: S
authors.lastname: Cascinu
authors.forename: P
authors.initials: P
authors.lastname: Foa
authors.forename: L
authors.initials: L
authors.lastname: Frontini
authors.forename: R
authors.initials: R
authors.lastname: Labianca
authors.forename: G
authors.initials: G
authors.lastname: Luporini
authors.forename: M
authors.initials: M
authors.lastname: Mandalà
authors.forename: G
authors.initials: G
authors.lastname: Martignoni
authors.forename: G
authors.initials: G
authors.lastname: Pancera
authors.forename: A
authors.initials: A
authors.lastname: Sobrero
authors.forename: A
authors.initials: A
authors.lastname: Zaniboni
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D005472:Fluorouracil / Q000627:therapeutic use; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009367:Neoplasm Staging; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D007155:Immunologic Factors; D007978:Levamisole; D005492:Folic Acid; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate
vernacular_title: Trattamento adiuvante del carcinoma del colon. Stato dell'arte e prospettive future.